A three-dose, oral rotavirus vaccine (Rotavac) was introduced in the universal immunization program in India in 2016. A prelicensure trial involving 6799 infants was not large enough to detect a small increased risk of intussusception. Postmarketing surveillance data would be useful in assessing whether the risk of intussusception would be similar to the risk seen with different rotavirus vaccines used in other countries. We conducted a multicenter, hospital-based, active surveillance study at 27 hospitals in India. Infants meeting the Brighton level 1 criteria of radiologic or surgical confirmation of intussusception were enrolled, and rotavirus vaccination was ascertained by means of vaccination records. The relative incidence (incidence during the risk window vs. all other times) of intussusception among infants 28 to 365 days of age within risk windows of 1 to 7 days, 8 to 21 days, and 1 to 21 days after vaccination was evaluated by means of a self-controlled case-series analysis. For a subgroup of patients, a matched case–control analysis was performed, with matching for age, sex, and location. From April 2016 through June 2019, a total of 970 infants with intussusception were enrolled, and 589 infants who were 28 to 365 days of age were included in the self-controlled case-series analysis. The relative incidence of intussusception after the first dose was 0.83 (95% confidence interval [CI], 0.00 to 3.00) in the 1-to-7-day risk window and 0.35 (95% CI, 0.00 to 1.09) in the 8-to-21-day risk window. Similar results were observed after the second dose (relative incidence, 0.86 [95% CI, 0.20 to 2.15] and 1.23 [95% CI, 0.60 to 2.10] in the respective risk windows) and after the third dose (relative incidence, 1.65 [95% CI, 0.82 to 2.64] and 1.08 [95% CI, 0.69 to 1.73], respectively). No increase in intussusception risk was found in the case–control analysis. The rotavirus vaccine produced in India that we evaluated was not associated with intussusception in Indian infants. (Funded by the Bill and Melinda Gates Foundation and others.)
WHO defines adolescence age between 10 to 19 years. In India, there are 243 million adolescents which constitute 21 per cent of the total population. The global burden of disease in adolescents (2011) reports that the total number of disability adjusted life years (DALYs) worldwide among adolescents were 230 million which constitutes 15.5% of total DALYs. The immunization is one of the most important, most beneficial and cost-effective disease prevention measures that can be provided for adolescents. The adolescent vaccination protects most of the world’s adolescents from a number of infectious diseases that previously claimed millions of lives each year. In India, thousands of adolescents die and thousands are hospitalized every year due to communicable diseases that could have been prevented by vaccination. Main aims of adolescent vaccinations are: to boost immunity status that is waning after completion of primary immunization or absence of “natural” boosting due exposure to the particular disease. The...
1 January 2014 in Indian Journal of Public Health Research & Development
Background Considerable evidence suggests a role for micronutrients in pregnancy outcomes. This study was conducted to evaluate the effect of maternal micronutrients supplementation on the birth weight of their babies. Method A randomized controlled trial was conducted between 1st Sept. 2009 to 30th Nov. 2010 at Pt. B.D. Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak (Haryana) in the Department of Pediatrics and Department of Obstetrics and Gynecology. Study involved 560 pregnant women of 12 to 14 weeks gestation, out of which 280 received multiple micronutrients supplement tablet and other 280 received iron and folic acid in tablet once daily after meals. Results The gestational age, birth weight and birth length were significantly higher in the multiple micronutrients supplement group as compared to the iron folic acid group. The proportion of Low Birth Weight was reduced by 22.5% and period of gestational was 0.45 weeks higher in study group as compared to iron folic acid group (p<0.001). Birth length was 0.62 cm higher in study group (p<0.01). Conclusions Multiple micronutrients (MMN) supplementation can be beneficial for reducing the incidence of low birth weight (LBW) and preterm delivery also mortality and morbidity in neonates.